Sensitive markers of inflammation make it possible to study the chronic process: the rise of interest in low levels of C-reactive protein

Author： Kluft C.   de Maat M.P.M.  

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.39, Iss.3, 2002-08, pp. : 99-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Correlation of human S100A12 (EN-RAGE) and high-sensitivity C-reactive protein as gingival crevicular fluid and serum markers of inflammation in chronic periodontitis and type 2 diabetes

By Pradeep A.   Martande Santosh   Singh Sonender   Suke Deepak   Raju Arjun   Naik Savitha  

Inflammation Research, Vol. 63, Iss. 4, 2014-04 ,pp. : 317-323

Springer Publishing Company

Access to resources Recommend Favorite

QOL effects of C-reactive protein levels in diabetes

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 442, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Relating statin therapy to C-reactive protein levels

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1597-1600

Informa Healthcare

Access to resources Recommend Favorite

Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population

By Andreassen Mikkel   Raymond Ilan   Hildebrandt Per   Kistorp Caroline   Rathcke Camilla   Vestergaard Henrik   Faber Jens   Kristensen Lars  

Inflammation Research, Vol. 59, Iss. 7, 2010-07 ,pp. : 503-510

Springer Publishing Company

Access to resources Recommend Favorite

C-Reactive Protein and Asymmetric Dimethylarginine: Markers or Mediators in Cardiovascular Disorders?

By  

Current Pharmaceutical Design, Vol. 13, Iss. 16, 2007-06 ,pp. : 1619-1629

Bentham Science Publishers

Access to resources Recommend Favorite